Clinical studies recruiting near Surat

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 3560001 · Sanofi · NCT06867094 An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06666491 'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'
Phase N/A · Srijan Children Gastro & Liver Clinic · Institute of Liver and Biliary Sciences, India · NCT06396546 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Add
Phase 4 · Surat Institute of Digestive Sciences · Bayer · NCT05348876 A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
Phase 3 · Nirmal Hospital Pvt. Ltd. · Novo Nordisk A/S · NCT05685238 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Nirmal Hospital Pvt Ltd. · Eli Lilly and Company · NCT07223593 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Phase 1 · Nirmal Hospital Pvt Ltd. · Pfizer · NCT06703606 A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropeni
Phase 3 · Nirmal Hospital Private Limited · X4 Pharmaceuticals · NCT06056297 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio, Inc. · NCT06419374 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Sunshine Global Hospital (A unit of Baroda Medicare Pvt Ltd) · Hoffmann-La Roche · NCT05894239 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Surat Institute of Digestive Sciences · Boehringer Ingelheim · NCT06632457 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
Phase 2 · Investigational Site Number : 3560013 · Sanofi · NCT06637631 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · Nirmal Hospital Pvt Ltd. · Eli Lilly and Company · NCT07392190 Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-sm
Phase 3 · Nirmal Hospital Private Limited · Daiichi Sankyo · NCT06899126 A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vern
Phase 2 · Shivam Retina Clinic and Eye Hospital · Laboratoires Thea · NCT07169695 A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Phase 3 · BAPS Pramukh Swami Hospital · Novo Nordisk A/S · NCT07253285 A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Phase 3 · Research Site · AstraZeneca · NCT06549595 A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · Universal Superspeciality Hospital · Aurigene Discovery Technologies Limited · NCT05865002 Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy o
Phase 3 · Research Site · AstraZeneca · NCT06380751 Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Phase 3 · Nirmal Hospital Pvt Ltd. · Pfizer · NCT05145127 A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
Phase 4 · Site IN91001 · Astellas Pharma Global Development, Inc. · NCT06862219 AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Can
Phase 3 · Research Site · AstraZeneca · NCT07218809 A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Phase 2 · Spyre Therapeutics, Inc. · NCT07012395 A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06215716 A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe
Phase 3 · Unity Hospital · Boehringer Ingelheim · NCT07361302 LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or A
Phase 3 · Surat Institute of Digestive Sciences · Boehringer Ingelheim · NCT06632444

Look up another city

Look up another condition